Clinical overview of venous thromboembolism

Abstract

Pulmonary embolism and deep venous thrombosis constitute a major cause of vascular illness in the USA. The mortality rate of pulmonary embolism is high, and recurrent events frequently occur. The optimal duration of treatment with anticoagulation is unknown. Diagnostic work-ups now often include plasma D-dimer levels and echocardiography in addition to conventional lung scanning and pulmonary angiography. Among patients with right ventricular dysfunction, thrombolytic therapy is being used more often because this strategy may improve overall prognosis. Since venous thromboembolism is difficult to diagnose and expensive to treat, prophylaxis against this disease is of paramount importance.

Keywords

deep venous thrombosis pulmonary embolism venous thromboembolism venous thrombosis

References

Goldhaber SZ , De Rosa M , Visani L. International Cooperative Pulmonary Embolism Registry detects high mortality rate. Circulation 1997; 96(suppl I): I-159 (abstract).

Schulman S , Rhedin A-S , Lindmarker P et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661-1665.

Prandoni P , Lensing AWA , Cogo A et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.

Goldhaber SZ , Grodstein F , Stampfer MJ et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277: 642-645.

World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception . Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995; 346: 1575-1582.

World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception . Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582-1588.

Jick H , Jick SS , Gurewich V , Myers MW , Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-1593.

Daly E , Vessey MP , Hawkins MM , Carson JL , Gough P , Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977-980.

Jick H , Derby LE , Myers MW , Vasilakis C , Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996; 348: 981-983.

10.

Grodstein F , Stampfer MJ , Goldhaber SZ et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983-987.

11.

Price DT , Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997; 127: 895-903.

12.

D’Angelo A , Selhub J. Homocysteine and thrombotic disease. Blood 1997; 90: 1-11.

13.

Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344.

14.

Heijboer H , Brandjes DPM , Büller HR , Sturk A , ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in out-patients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-1516.

15.

van den Belt AGM , Sanson B-J , Simioni P et al. Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Intern Med 1997; 157: 2227-2232.

16.

Ridker PM , Hennekens CH , Selhub J , Miletich JP , Malinow MR , Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 1997; 95: 1777-1782.

17.

Ferrari E , Imbert A , Chevalier T , Mihoubi A , Morand P , Baudouy M. The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads - 80 case reports. Chest 1997; 111: 537-543.

18.

Stein PD , Goldhaber SZ , Henry JW , Miller AC. Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest 1996; 109: 78-81.

19.

Stein PD , Goldhaber SZ , Henry JW. Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest 1995; 107: 139-143.

20.

Bounameaux H , de Moerloose P , Perrier A , Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994; 71: 1-6.

21.

Bounameaux H , de Moerloose P , Perrier A , Miron MJ. D-dimer testing in suspected venous thromboembolism: an update. Q J Med 1997; 90: 437-442.

22.

Moser KM , Fedullo PF , LitteJohn JK , Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994; 271: 223-225.

23.

Turkstra F , Kuijer PMM , van Beek EJR , Brandjes DPM , ten Cate JW , Büller HR. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 1997; 126: 775-781.

24.

PIOPED Investigators . Value of the ventilation perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 2753-2759.

25.

Bone RC. The low-probability lung scan. A potentially lethal reading. Arch Intern Med 1993; 153: 2621-2622.

26.

Hull RD , Raskob GE , Pineo GF , Brant RF. The low-probability lung scan. A need for change in nomenclature. Arch Intern Med 1995; 155: 1845-1851.

27.

Remy-Jardin M , Remy J , Deschildre F et al. Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 1996; 200: 699-706.

28.

Meaney JFM , Weg JG , Chenevert TL , Stafford-Johnson D , Hamilton BH , Prince MR. Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 1997; 336: 1422-1427.

29.

Jardin F , Dubourg O , Bourdarias JP. Echocardiographic pattern of acute cor pulmonale. Chest 1997; 111: 209-217.

30.

McConnell MV , Solomon SD , Rayan ME , Come PC , Goldhaber SZ , Lee RT. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996; 78: 769-773.

31.

Stein PD , Athanasoulis C , Alavi A et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 1992; 85: 462-468.

32.

Raschke RA , Reilly BM , Guidry JR , Fontana JR , Srinivas S. The weight-based heparin dosing nomogram compared with a ‘standard care’ nomogram: a randomized controlled trial. Ann Intern Med 1993; 119: 874-881.

33.

Toglia MR , Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996; 335: 108-114.

34.

Callander N , Rapaport SI. Trousseau’s Syndrome. West J Med 1993; 158: 364-371.

35.

The COLUMBUS Investigators . Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657-662.

36.

Simonneau G , Sors H , Charbonnier B et al for the THÉSÉE Study Group. A comparison of low-molecular-weight-heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663-669.

37.

Koopman MMW , Prandoni P , Piovella F et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334: 682-687.

38.

Levine M , Gent M , Hirsh J et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-681.

39.

Harrison L , Johnston M , Massicotte MP , Crowther M , Moffat K , Hirsh J. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 1997; 126: 133-136.

40.

Schulman S , Granqvist S , Holmström M et al and the Duration of Anticoagulation Trial Study Group. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997; 336: 393-398.

41.

Decousus H for the PREPIC Group . A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis. N Engl J Med 1998; 338: 409-415.

42.

Pacouret G , Alison D , Pottier J-M , Bertrand P , Charbonnier B. Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis. A prospective study. Arch Intern Med 1997; 157: 305-308.

43.

The Urokinase Pulmonary Embolism Trial . A national cooperative study. Circulation 1973; 47: II-1-II-108.

44.

Urokinase-Streptokinase Embolism Trial . Phase 2 results. A cooperative study. JAMA 1974; 229: 1606-1613.

45.

Jerjes-Sanchez C , Ramirez-Rivera A , Garcia M de L et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thrombos Thrombol 1995; 2: 227-229.

46.

Goldhaber SZ , Haire WD , Feldstein ML et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-511.

47.

Ribeiro A , Lindmarker P , Juhlin-Dannfelt A , Johnsson H , Jorfeldt L. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as predictor of mortality. Am Heart J 1997; 134: 479-487.

48.

Kasper W , Konstantinides S , Geibel A , Tiode N , Krause T , Just H. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 1997; 77: 346-349.

49.

Kasper W , Konstantinides S , Geibel A et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30: 1165-1171.

50.

Kanter DS , Mikkola KM , Patel SR , Parker JA , Goldhaber SZ. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest 1997; 111: 1241-1245.

51.

Mikkola KM , Patel SR , Parker JA , Grodstein F , Goldhaber SZ. Increasing age is a major risk factor for hemorrhagic complications following pulmonary embolism thrombolysis. Am Heart J 1997; 134: 69-72.

52.

Daniels LB , Parker JA , Patel SR , Grodstein F , Goldhaber SZ. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol 1997; 80: 184-188.

53.

Goldhaber SZ. Contemporary pulmonary embolism thombolysis. Chest 1995; 107: 45S-51S.

54.

Greenfield LJ , Proctor MC , Williams DM , Wakefield TW. Long-term experience with transvenous catheter pulmonary embolectomy. J Vasc Surg 1993; 18: 450-458.

55.

Gulba DC , Schmid C , Borst H-G , Lichtlen P , Dietz R , Luft FC. Medical compared with surgical treatment for massive pulmonary embolism. Lancet 1994; 343: 576-577.

56.

Goldhaber SZ , Buring JE , Lipnick RJ , Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76: 393-397.

57.

Brown WD , Goldhaber SZ. How to select patients with deep vein thrombosis for tPA therapy. Chest 1989; 95: 276S-278S.

58.

Markel A , Manzo RA , Strandness DE Jr. The potential role of thrombolytic therapy in venous thrombosis. Arch Intern Med 1992; 152: 165-167.

59.

Meyerovitz MF , Polak JF , Goldhaber SZ. Short-term response to thrombolytic therapy in deep venous thrombosis: predictive value of venographic appearance. Radiology 1992; 184: 345-348.

60.

Théry C , Bauchart JJ , Lesenne M et al. Predictive factors of effectiveness of streptokinase in deep venous thrombosis. Am J Cardiol 1992; 69: 117-122.

61.

Collins R , Scrimgeour A , Yusuf S , Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318: 1162-1173.

62.

Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-698.

63.

Hoek JA , Nurmohamed MT , Hamelynck KJ et al. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost 1992; 67: 28-32.